FAA orders 10% flight reduction as the U.S. government shutdown cripples airlines, disrupts travel, and threatens ...

An increase of more than 0.75 ng/mL has also been considered as a cutoff to begin a more thorough workup. However, the PSA ...

I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly physical exam with my ...

I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family ...

Prostate cancer is one of the most commonly diagnosed cancers in men. According to the Irish Cancer Society, around 4,000 men in Ireland are told they have it every year, and one in six can expect to ...

As part of an EU-wide initiative to screen for prostate cancer, researchers in Ireland are studying whether a simple home finger-prick PSA blood test can help detect the disease earlier and save more ...

Pinar Uysal-Onganer receives funding from Prostate Cancer UK. Alwyn Dart does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen deprivation therapy cuts the risk of death by 40% over 8 years, according to ...

Type 2 diabetes is a long-term condition where your body either doesn’t produce enough insulin or can’t use the insulin it makes properly, causing blood sugar levels to rise. Keeping an eye on your ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Prostate is the cancer most commonly diagnosed in men. It affects one in six and the risk escalates with age. “If they live long enough, all men develop areas of cancer in their prostate,” says Mr ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...